Doxorubicin enhances nucleosome turnover around promoters

Current Biology

Volumn 23, Issue 9, 2013, Pages 782-787

  Yang, Fan ^a   Kemp, Christopher J ^a   Henikoff, Steven ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

ACLARUBICIN; ANTINEOPLASTIC ANTIBIOTIC; ATM PROTEIN; ATM PROTEIN, MOUSE; DOXORUBICIN; NUCLEOSOME; PROTEIN P53;

ANIMAL; DRUG EFFECTS; METABOLISM; MICROARRAY ANALYSIS; MOUSE; NUCLEOSOME; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR CELL CULTURE;

ACLARUBICIN; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ATAXIA TELANGIECTASIA MUTATED PROTEINS; DOXORUBICIN; MICE; MICROARRAY ANALYSIS; NUCLEOSOMES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877585708     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2013.03.043     Document Type: Article

References (40)

1. W.A. Denny DNA-intercalating ligands as anti-cancer drugs: prospects for future design Anticancer Drug Des. 4 1989 241 263
2. R.B. Deal, J.G. Henikoff, and S. Henikoff Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones Science 328 2010 1161 1164
3. S.S. Teves, R.B. Deal, and S. Henikoff Measuring genome-wide nucleosome turnover using CATCH-IT Methods Enzymol. 513 2012 169 184
4. S.S. Teves, and S. Henikoff Heat shock reduces stalled RNA polymerase II and nucleosome turnover genome-wide Genes Dev. 25 2011 2387 2397
5. C.J. Kemp Multistep skin cancer in mice as a model to study the evolution of cancer cells Semin. Cancer Biol. 15 2005 460 473
6. E.L. Abel, J.M. Angel, K. Kiguchi, and J. DiGiovanni Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications Nat. Protoc. 4 2009 1350 1362
7. S.L. Bailey, K.E. Gurley, K. Hoon-Kim, K.S. Kelly-Spratt, and C.J. Kemp Tumor suppression by p53 in the absence of Atm Mol. Cancer Res. 6 2008 1185 1192
8. A. Barski, S. Cuddapah, K. Cui, T.Y. Roh, D.E. Schones, Z. Wang, G. Wei, I. Chepelev, and K. Zhao High-resolution profiling of histone methylations in the human genome Cell 129 2007 823 837
9. A. Barski, I. Chepelev, D. Liko, S. Cuddapah, A.B. Fleming, J. Birch, K. Cui, R.J. White, and K. Zhao Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes Nat. Struct. Mol. Biol. 17 2010 629 634
10. M. Ku, J.D. Jaffe, R.P. Koche, E. Rheinbay, M. Endoh, H. Koseki, S.A. Carr, and B.E. Bernstein H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions Genome Biol. 13 2012 R85
11. A.D. Goldberg, L.A. Banaszynski, K.M. Noh, P.W. Lewis, S.J. Elsaesser, S. Stadler, S. Dewell, M. Law, X. Guo, and X. Li Distinct factors control histone variant H3.3 localization at specific genomic regions Cell 140 2010 678 691
12. L.D. Attardi, A. de Vries, and T. Jacks Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer Oncogene 23 2004 973 980
13. S.M. Vos, E.M. Tretter, B.H. Schmidt, and J.M. Berger All tangled up: how cells direct, manage and exploit topoisomerase function Nat. Rev. Mol. Cell Biol. 12 2011 827 841
14. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat. Rev. Cancer 2 2002 594 604
15. M.L. Poeta, J. Manola, M.A. Goldwasser, A. Forastiere, N. Benoit, J.A. Califano, J.A. Ridge, J. Goodwin, D. Kenady, and J. Saunders TP53 mutations and survival in squamous-cell carcinoma of the head and neck N. Engl. J. Med. 357 2007 2552 2561
16. N. Agrawal, M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, R.J. Li, C. Fakhry, T.X. Xie, J. Zhang, and J. Wang Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
17. J.G. Jackson, V. Pant, Q. Li, L.L. Chang, A. Quintás-Cardama, D. Garza, O. Tavana, P. Yang, T. Manshouri, and Y. Li p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer Cancer Cell 21 2012 793 806
18. H. Jiang, H.C. Reinhardt, J. Bartkova, J. Tommiska, C. Blomqvist, H. Nevanlinna, J. Bartek, M.B. Yaffe, and M.T. Hemann The combined status of ATM and p53 link tumor development with therapeutic response Genes Dev. 23 2009 1895 1909
19. E.U. Kurz, P. Douglas, and S.P. Lees-Miller Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species J. Biol. Chem. 279 2004 53272 53281
20. O. Bornachea, M. Santos, A.B. Martínez-Cruz, R. García-Escudero, M. Dueñas, C. Costa, C. Segrelles, C. Lorz, A. Buitrago, and C. Saiz-Ladera EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours Sci. Rep. 2 2012 434
21. O. Laptenko, R. Beckerman, E. Freulich, and C. Prives p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation Proc. Natl. Acad. Sci. USA 108 2011 10385 10390
22. Y. Shiloh The ATM-mediated DNA-damage response: taking shape Trends Biochem. Sci. 31 2006 402 410
23. C.E. Canman, D.S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 Science 281 1998 1677 1679
24. S. Burma, B.P. Chen, M. Murphy, A. Kurimasa, and D.J. Chen ATM phosphorylates histone H2AX in response to DNA double-strand breaks J. Biol. Chem. 276 2001 42462 42467
25. W.M. Bonner, C.E. Redon, J.S. Dickey, A.J. Nakamura, O.A. Sedelnikova, S. Solier, and Y. Pommier GammaH2AX and cancer Nat. Rev. Cancer 8 2008 957 967
26. M. Svetlova, L. Solovjeva, K. Nishi, I. Nazarov, J. Siino, and N. Tomilin Elimination of radiation-induced gamma-H2AX foci in mammalian nucleus can occur by histone exchange Biochem. Biophys. Res. Commun. 358 2007 650 654
27. J.S. Siino, I.B. Nazarov, M.P. Svetlova, L.V. Solovjeva, R.H. Adamson, I.A. Zalenskaya, P.M. Yau, E.M. Bradbury, and N.V. Tomilin Photobleaching of GFP-labeled H2AX in chromatin: H2AX has low diffusional mobility in the nucleus Biochem. Biophys. Res. Commun. 297 2002 1318 1323
28. Y. Pommier, E. Leo, H. Zhang, and C. Marchand DNA topoisomerases and their poisoning by anticancer and antibacterial drugs Chem. Biol. 17 2010 421 433
29. P.B. Jensen, B.S. Sørensen, E.J. Demant, M. Sehested, P.S. Jensen, L. Vindeløv, and H.H. Hansen Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4′-(9-acridinylamino)methanesulfon-m- anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage Cancer Res. 50 1990 3311 3316
30. J. Zlatanova, and J.M. Victor How are nucleosomes disrupted during transcription elongation? HFSP J. 3 2009 373 378
31. L.F. Liu, and J.C. Wang Supercoiling of the DNA template during transcription Proc. Natl. Acad. Sci. USA 84 1987 7024 7027
32. H.Y. Wu, S.H. Shyy, J.C. Wang, and L.F. Liu Transcription generates positively and negatively supercoiled domains in the template Cell 53 1988 433 440
33. C.A. Lovejoy, W. Li, S. Reisenweber, S. Thongthip, J. Bruno, T. de Lange, S. De, J.H. Petrini, P.A. Sung, M. Jasin ALT Starr Cancer Consortium Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway PLoS Genet. 8 2012 e1002772
34. J. Namur, S.J. Citron, M.T. Sellers, M.H. Dupuis, M. Wassef, M. Manfait, and A. Laurent Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants J. Hepatol. 55 2011 1332 1338
35. M. Lehmann, Kde.S. Vilar, A. Franco, M.L. Reguly, and H.H. Rodrigues de Andrade Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test Environ. Mol. Mutagen. 43 2004 250 257
36. S. Peng, A.A. Alekseyenko, E. Larschan, M.I. Kuroda, and P.J. Park Normalization and experimental design for ChIP-chip data BMC Bioinformatics 8 2007 219
37. M.L. Conerly, S.S. Teves, D. Diolaiti, M. Ulrich, R.N. Eisenman, and S. Henikoff Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis Genome Res. 20 2010 1383 1390
38. D. Tabas-Madrid, R. Nogales-Cadenas, and A. Pascual-Montano GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics Nucleic Acids Res. 40 Web Server issue 2012 W478 W483
39. P. Carmona-Saez, M. Chagoyen, F. Tirado, J.M. Carazo, and A. Pascual-Montano GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists Genome Biol. 8 2007 R3
40. R. Nogales-Cadenas, P. Carmona-Saez, M. Vazquez, C. Vicente, X. Yang, F. Tirado, J.M. Carazo, and A. Pascual-Montano GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information Nucleic Acids Res. 37 Web Server issue 2009 W317 W322